Médico especialista en Medicina nuclear y PET/CT Encargada División Medicina Nuclear y PET/CT INCART Docente UNPHU
FINALLY! https://lnkd.in/diJbCUcg Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer, Offers Potential for Targeted Therapy #snmmi #PET #NUCLEARMEDICINE #MEDULLARY #THYROID #CANCER
I feel happy to share my recently published research article in Cellular and Molecular Life Sciences elucidating the importance of target deubiquitinating enzymes in cisplatin-resistant cancer cells. #cancer #cancerresearch #therapeutics #cisplatintherapy https://lnkd.in/gSgr5gMC
Evaluation of role of angiotensin IIi and aminopeptidases in prostate cancer cells https://t.co/9akxoPxyDp #EurekaMag
Want to learn more about the relevance of detecting PSMA positivity in advanced prostate cancer patients from a simple blood test? Check out this great interview in Targeted Oncology with our collaborator Dr. Jacob Berchuck. https://bit.ly/4e7gBvE #ProstateCancer #Epigenomics #PrecisionMedicine #DrugDevelopment
Looking for Postdoc position in Organic Chemistry/Medicinal Chemistry/Polymer Chemistry
Dear all I am pleased to share our article entitled "Synergistic chemo-photothermal therapy using gold nanorods supported on thiol-functionalized mesoporous silica for lung cancer treatment" in Scientific Reports (IF: 4.996).
The validation of the miRNA assay for #pancsm in each cohort: ▪️USA: 93% ▪️China: 88% ▪️South Korea 91% https://lnkd.in/e6jQXPGy #AACR24 #cancer #oncology
How to fully untap the #anti_tumoral potential of #siRNA? Scientists have come up with a smart way to #deliver this drug modality to tumor cells by optimizing the divalent lipid-conjugated siRNAs for in situ binding to albumin. A preclinical proof of concept was achieved in a model of orthotopic triple negative breast cancer (TNBC) tumors, where the Lead molecule showed greater PK/PD properties than the parent molecule. https://lnkd.in/ehvxYd9u
Initial data from the phase 1/2 COBRA study support the safety and efficacy of 64Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy. https://lnkd.in/ehz6b66B
Pretty chuffed to finally get this review article out there. Highlights just one of the ways that nanomedicines can be utilised to improve clinical efficacy of cancer treatments. https://lnkd.in/gUaTYPxP
TellBio's latest study shows analyzing circulating tumor cells (CTCs) can predict survival in men with advanced prostate cancer undergoing radium-223 therapy. This could lead to more personalized treatment approaches and better outcomes! #prostatecancer #CTC #TellBio #precisionmedicine
🤗Check out this review: How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 🎓by Dr. Cogliati et al., from the ASST Monza, Italy. 📄Read more: https://lnkd.in/ezXZXRJA #metastatic breast cancer; #CDK4/6 inhibitors; #therapy resistance; #treatment sequencing
